BRCA1 and neoplasm: In the MINAS historical subgroup it was estimated that 14.6% of patients (13/89) had at least one tumour type that was not typical of the relevant CSGs (e.g. renal clear cell carcinoma in a patient with variants in both BRCA1 and MLH1) [12].